Medical News

RSS

Women can benefit from Ontario's breast cancer screening program

The Ontario Budget has taken a step toward providing the type of expanded screening for breast cancer that Ontario women need, the Canadian Breast Cancer Foundation —Ontario Region says.

30 Mar 2011

With clock ticking, budget impasse continues

The next deadline for a possible government shutdown is fast approaching, but lawmakers continue to be at odds over finalizing a current-year spending bill. Key among the stumbling blocks are legislative riders, including conservative-backed amendments that would cut off funding for the health law and advance other contentious social issues.

30 Mar 2011

New system can improve patient adherence to colonoscopy recommendations, reduce disparities

The simple practice of letters and a telephone call to patients who are due for a colonoscopy significantly improves adherence to endoscopic follow-up recommendations, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association Institute.

30 Mar 2011

Nanotechnology-based biosensor may allow early cancer, pathogen detection

A nanotechnology-based biosensor being developed by Kansas State University researchers may allow early detection of both cancer cells and pathogens, leading to increased food safety and reduced health risks.

30 Mar 2011

California's aging LGB more likely to suffer from certain chronic conditions

Members of California's aging lesbian, gay and bisexual population are more likely to suffer from certain chronic conditions, even as they wrestle with the challenges of living alone in far higher numbers than the heterosexual population, according to new policy brief from the UCLA Center for Health Policy Research.

30 Mar 2011

WHO Director-General responds to draft report on agency's handling of H1N1 pandemic

WHO Director-General Margaret Chan on Monday responded to the first results of a probe into the agency's response to the H1N1 pandemic, Agence France-Presse reports.

30 Mar 2011

SLN to present Atu027 Phase I study data against solid cancer at ASCO Annual Meeting

Silence Therapeutics plc a leading global RNA interference therapeutics company, announces that interim data from its ongoing Phase I clinical study of Atu027, the Company's lead internal therapeutic candidate, have been accepted for poster presentation at the 2011 American Society of Clinical Oncology Annual Meeting.

30 Mar 2011

CancerForward announces new national outreach and partnering program

CancerForward: The Foundation for Cancer Survivors today announced the creation of ConnectToForward, a fundamental initiative of the Foundation's three-prong mission to connect, educate and share information among cancer survivors through its website, cancerforward.org.

30 Mar 2011

Unilife initiates Unifill syringe production for pharmaceutical companies

Unilife Corporation today announced it has commenced initial production of the Unifill ready-to-fill syringe at its FDA-registered manufacturing facility in York, Pennsylvania.

30 Mar 2011

New study: Periodontal therapy can help reduce medical costs for patients with diabetes

The results from a new CIGNA study support that there is a potential association between treated periodontal disease and reduced medical costs for patients with diabetes.

30 Mar 2011

Canadian Cancer Society applauds Ontario government for allocating new funding for Breast Screening Program

The Canadian Cancer Society is pleased women with a family history of breast cancer and other higher-risk women will now have access to high-quality breast screening through the Ontario Breast Screening Program.

30 Mar 2011

Merck submits Erbitux indication extension to EMA for NSCLC treatment

Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today that it has submitted an indication extension to the European Medicines Agency for the approval of Erbitux in combination with standard 1st line platinum-based chemotherapy in patients with advanced or metastatic non-small cell lung cancer with high epidermal growth factor receptor expression.

30 Mar 2011

Accelrys announces Modeling and Simulation Suite for optimizing R&D value chain

Accelrys, Inc., a leading scientific enterprise R&D software and services company, today announced the Accelrys Modeling and Simulation Suite, a pillar of the new Accelrys Enterprise R&D Architecture.

30 Mar 2011

Pathfinder cell-based therapy reverses diabetes in mouse model

Pathfinder, LLC, a private biotechnology company focused on the treatment of diseases characterized by organ-specific cell damage, today announced publication of promising preclinical data demonstrating that the Company's unique cell-based therapy is able to completely reverse diabetes in a mouse model.

30 Mar 2011

SAMHSA publishes strategic initiatives paper on nation's behavioral health care system

The Substance Abuse and Mental Health Services Administration today published its strategic initiatives paper - an overview of SAMHSA's goals, priorities and action steps for accomplishing its mission of reducing the impact of substance abuse and mental illness on America's communities.

30 Mar 2011

Insect Shield Repellent Apparel can protect against tick bites

A pilot study shows clothes treated with long-lasting insect repellant appear to offer outdoor workers significant protection against tick bites.

30 Mar 2011

ADI, Fondation Médéric Alzheimer honor Britain's psychiatry professor with international award

Dr. Sube Banerjee, one of the world's leading experts on Alzheimer's disease is the recipient of an international award for the best evidence-based psychosocial intervention for people with dementia and their caregivers.

30 Mar 2011

UT Southwestern Medical Center tops best hospital rankings for Dallas-Fort Worth

UT Southwestern Medical Center ranked as the best hospital in Dallas-Fort Worth in the newly expanded U.S. News & World Report's America's Best Hospitals rankings for 52 metropolitan areas.

30 Mar 2011

Vexim granted FDA approval for COHESION bone cement

Vexim specialises in medical instruments and the minimally invasive treatment of vertebral fractures. The company recently announced that it had been awarded FDA certification for its flagship product COHESION™, a bone cement for injection into the vertebra for its fixation following minimally invasive spine repair with the company's SpineJack® device, or following conventional vertebroplasty.

30 Mar 2011

Almac inaugurates new CLIA registered laboratory

Almac's Diagnostics business unit today announced the opening of its CLIA registered laboratory.

30 Mar 2011

Medical News

Women can benefit from Ontario's breast cancer screening program

With clock ticking, budget impasse continues

New system can improve patient adherence to colonoscopy recommendations, reduce disparities

Nanotechnology-based biosensor may allow early cancer, pathogen detection

California's aging LGB more likely to suffer from certain chronic conditions

WHO Director-General responds to draft report on agency's handling of H1N1 pandemic

SLN to present Atu027 Phase I study data against solid cancer at ASCO Annual Meeting

CancerForward announces new national outreach and partnering program

Unilife initiates Unifill syringe production for pharmaceutical companies

New study: Periodontal therapy can help reduce medical costs for patients with diabetes

Canadian Cancer Society applauds Ontario government for allocating new funding for Breast Screening Program

Merck submits Erbitux indication extension to EMA for NSCLC treatment

Accelrys announces Modeling and Simulation Suite for optimizing R&D value chain

Pathfinder cell-based therapy reverses diabetes in mouse model

SAMHSA publishes strategic initiatives paper on nation's behavioral health care system

Insect Shield Repellent Apparel can protect against tick bites

ADI, Fondation Médéric Alzheimer honor Britain's psychiatry professor with international award

UT Southwestern Medical Center tops best hospital rankings for Dallas-Fort Worth

Vexim granted FDA approval for COHESION bone cement

Almac inaugurates new CLIA registered laboratory

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News